Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
EDINA, Minn., April 30, 2019 National Cardiovascular Partners, LP (NCP), a leading nationwide developer, manager and operator of outpatient cardiovascular facilities, today announced a new joint venture partnership with Mesa Cardiovascular Research Center, an outpatient cardiovascular center in Mesa, AZ.
This is NCP's fourth joint venture partnership in Arizona. As part of the deal, NCP will assume the daily management and operations of the cardiovascular center, as well as credentialing, administrative and billing functions, freeing up the center's physicians to focus exclusively on providing the highest quality of patient care. Mesa Cardiovascular Research Center will become part of NCPís network of 25 Outpatient Centers throughout the United States.
"NCP will be a tremendous corporate partner in the center and allow us to solely focus on patient quality and care," said Dr. Andrew Kaplan, a physician partner with Mesa Cardiovascular Research Center. "NCP shares our vision of excellent and efficient cardiovascular care, and together, we will take patient care to the next level." This new joint venture partnership was formed with NCP with a vision of combining years of clinical experience with years of corporate experience. Both Dr. Kaplan and his partner, Dr. Al Ambrosia, bring more than 40 years' experience in Electrophysiology and Interventional Cardiology. The physicians will be performing device implants and ablations, as well as peripheral vascular arterial and venous procedures, coronary, carotid and renal artery procedures.
"We are excited to have Mesa Cardiovascular Research Center as part of our family of high-quality outpatient centers," said Brian Gauger, President & CEO of NCP. "The combination of their cardiovascular procedures and clinical research, along with our business expertise makes this the perfect partnership."
About Mesa Cardiovascular Research Center
Mesa Cardiovascular Research Centerís team of highly trained physicians and medical staff specialize in treating all types of cardiovascular disease in an outpatient setting, reducing the need for complex open surgeries.
For more about the cardiovascular center, please visit its website at https://mesacardiovascular.com.
About National Cardiovascular Partners
National Cardiovascular Partners, a division of Fresenius Medical Care North America, partners with physicians to create, sustain and grow independent ambulatory surgery centers and catheterization labs. Their focus is on hybrid surgery center and outpatient cardiac catheterization lab services, in partnership with physician entrepreneurs. NCP currently operates 24 surgery centers throughout the US.
Learn more about NCP at https://fmcna.com/physician-solutions/cardiovascular-care/national-cardiovascular-partners/.
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world's largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals.
For more information, visit the FMCNA website at https://fmcna.com/.